Vitality Watch

Dossier clinicaltrials trial early 22-jul-2026
Small or early-phase human trial or pilot study

Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60

Key claim: An Rg1-based supplement (Senactiv®) is being tested as an adjunct to long-term exercise training to enhance bone marrow-derived stem cell recruitment and skeletal muscle adaptation, with potential to help prevent sarcopenia and cognitive decline in women over 60.

Abstract

This study will provide novel insights into the role of bone marrow-derived stem cells in muscle adaptation to long-term exercise and advance our understanding of an Rg-1 based supplement-Senactiv® as a potential intervention for preventing sarcopenia and cognitive decline in older adults.

Why this matters

Ginsenoside Rg1 already has a small human RCT signal in older women showing amplified stem-cell and mitochondrial responses to a single resistance-exercise bout; this protocol extends that lever into a longer training-adjunct design using a branded commercial formulation (Senactiv®), pushing the Rg1-plus-exercise story from acute biopsy readouts toward chronic adaptation and functional endpoints relevant to sarcopenia. It is one of the few active trials probing whether a TCM-derived compound can meaningfully augment the training response that remains the highest-tier lever in this area.

Source

Link

Briefing card

Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60
Stage: trial early · clinicaltrials · 22-jul-2026

If you are a woman over 60 considering Rg1 or Senactiv® alongside resistance training, this trial is testing exactly that combination but has not yet reported outcomes.

An Rg1-based supplement (Senactiv®) is being tested as an adjunct to long-term exercise training to enhance bone marrow-derived stem cell recruitment and skeletal muscle adaptation, with potential to help prevent sarcopenia and cognitive decline in women over 60.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07703774

build build 880 · 2bcef25 · 2026-11-18